Meitheal Pharmaceuticals Cisatracurium Besylate Injection Recall
FDA – January 27, 2021 - A voluntary recall alert was published by the U.S. Food and Drug Administration, Meitheal Pharmaceuticals, Inc. has issued a nationwide recall of its Cisatracurium Besylate Injection, USP 10mg per 5mL, because of a dangerous mislabeling error. The FDA alert is reporting that Meitheal Pharmaceuticals, Inc. … [Read more...] about Meitheal Pharmaceuticals Cisatracurium Besylate Injection Recall
